Reactive oxygen species and enzyme dual-responsive biocompatible drug delivery system for targeted tumor therapy
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 324, 330-340
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81201141)
- Clinical Capability Construction Project (LNCCC-D50-2015, LNCCC-C09-2015)
This publication has 37 references indexed in Scilit:
- Research Applications of Proteolytic Enzymes in Molecular BiologyBiomolecules, 2013
- Quantifying Thiol Ligand Density of Self-Assembled Monolayers on Gold Nanoparticles by Inductively Coupled Plasma–Mass SpectrometryACS Nano, 2013
- 11-Mercaptoundecanoic acid directed one-pot synthesis of water-soluble fluorescent gold nanoclusters and their use as probes for sensitive and selective detection of Cr3+and Cr6+Journal of Materials Chemistry C, 2012
- From Aggregation-Induced Emission of Au(I)–Thiolate Complexes to Ultrabright Au(0)@Au(I)–Thiolate Core–Shell NanoclustersJournal of the American Chemical Society, 2012
- Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug releaseBiomaterials, 2012
- Methotrexate—exploring dosing and administration in ALCLNature Reviews Clinical Oncology, 2009
- Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasisThe Journal of Pathology, 2006
- Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomasLaboratory Investigation, 2005
- Trypsin Cleaves Exclusively C-terminal to Arginine and Lysine ResiduesMolecular & Cellular Proteomics, 2004
- Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosisCancer Chemotherapy and Pharmacology, 2000